Zepbound is indicated for adults with obesity (with a BMI of 30 kg/m2 or greater), or those who are overweight (with a BMI of 27 kg/m2 or greater) and also have weight-related medical problems such as hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea or cardiovascular disease, to lose weight and keep it off
The FDA's ruling means: After April 22, 2025, 503A pharmacies must stop compounding, likely cutting off a key supply source for practices
As in all surgical procedures appropriate measures should be taken to minimize trauma to the cornea and other ocular tissues
Improves Skin Texture and Clarity
Although dose changes for warfarin are not typically needed when starting GLP-1 therapy, adjustments may be made based on your INR levels